Regulation of phase II enzymes by genistein and daidzein in male and female Swiss Webster mice.

The consumption of soy and soy isoflavones has been associated with a decreased risk of certain cancers. A factor contributing to this dietary chemoprevention is the activity of phase I and II biotransformation enzymes. This study evaluated the hypothesis that dietary soy isoflavones will increase hepatic and extrahepatic quinone reductase (QR), UDP-glucuronosyltransferase (UGT), and glutathione S-transferase (GST) phase II enzyme activities, under short-term feeding and basal (non-pharmacologic-induced) conditions. Male and female Swiss Webster mice were fed for 1, 3, 5, or 7 days of one of four treatments: control (casein AIN-93G) or control supplemented with flavone (positive control), genistein, or daidzein aglycones at 1,500 mg/kg of diet. QR activity was increased by daidzein in the liver, by both isoflavones in the kidney and small intestine, and by genistein in the heart. Genistein and daidzein slightly decreased UGT activities in some tissues. Liver GST activity was decreased by genistein in females. In contrast, genistein and daidzein increased kidney GST activity. In general, the greatest effects of isoflavones on phase II enzymes were observed in liver and kidney tissues, occurring at day 3, and peaking at day 5. Sex effects in the liver and kidney included females exhibiting higher QR activities and males exhibiting higher UGT and GST activities. In conclusion, individual soy isoflavones modulate phase II enzymes in mice under short-term feeding and basal conditions. This study provides insights into the actions of isolated isoflavones in mice.

[1]  Y. Ju,et al.  Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. , 2006, Carcinogenesis.

[2]  D. Lubahn,et al.  Repression of cancer protective genes by 17β-estradiol: Ligand-dependent interaction between human Nrf2 and estrogen receptor α , 2005, Molecular and Cellular Endocrinology.

[3]  H. Chun,et al.  Molecular and Absorption Properties of 12 Soy Isoflavones and Their Structure–Activity Relationship with Selected Biological Activities , 2005, Biotechnology Letters.

[4]  A. Mitchell,et al.  Direct liquid chromatography-mass spectrometry method for the detection of glutathione S-transferase isozymes and investigation of their expression in response to dietary flavone. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  A. Jaiswal,et al.  Nrf2 signaling in coordinated activation of antioxidant gene expression. , 2004, Free radical biology & medicine.

[6]  K. Setchell,et al.  Not all soy products are created equal: caution needed in interpretation of research results. , 2004, The Journal of nutrition.

[7]  Liliana Jiménez,et al.  Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.

[8]  R. Singal,et al.  Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications , 2004, Oncogene.

[9]  I. Rowland,et al.  Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer , 2004, British Journal of Nutrition.

[10]  X. Shu,et al.  Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. , 2003, The Journal of nutrition.

[11]  A. Clifford,et al.  Effect of Dietary Constituents With Chemopreventive Potential on Adduct Formation of a Low Dose of the Heterocyclic Amines PhIP and IQ and Phase II Hepatic Enzymes , 2003, Nutrition and cancer.

[12]  W. Peng,et al.  Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers , 2003, European Journal of Clinical Pharmacology.

[13]  P. Cooke,et al.  The phytoestrogen genistein suppresses cell-mediated immunity in mice. , 2003, The Journal of endocrinology.

[14]  K. Setchell,et al.  The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. , 2002, The Journal of nutrition.

[15]  G. Blackburn,et al.  Inhibition of orthotopic growth and metastasis of androgen‐sensitive human prostate tumors in mice by bioactive soybean components , 2002, The Prostate.

[16]  T. Walle,et al.  Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[17]  K. Setchell.  Soy Isoflavones—Benefits and Risks from Nature’s Selective Estrogen Receptor Modulators (SERMs) , 2001, Journal of the American College of Nutrition.

[18]  I. Eltoum,et al.  Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). , 2001, Cancer research.

[19]  A. Scalbert,et al.  Catechin is metabolized by both the small intestine and liver of rats. , 2001, The Journal of nutrition.

[20]  M. Ronis,et al.  Inducibility of hepatic CYP1A enzymes by 3-methylcholanthrene and isosafrole differs in male rats fed diets containing casein, soy protein isolate or whey from conception to adulthood. , 2001, The Journal of nutrition.

[21]  S. Inoue,et al.  Interaction of Phytoestrogens with Estrogen Receptors α and β , 2001 .

[22]  H. Adlercreutz,et al.  Interindividual Variation in Metabolism of Soy Isoflavones and Lignans: Influence of Habitual Diet on Equol Production by the Gut Microflora , 2000, Nutrition and cancer.

[23]  M. Reicks,et al.  Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats. , 1999, The Journal of nutrition.

[24]  H. Adlercreutz,et al.  Phytoestrogens and inhibition of angiogenesis. , 1998, Bailliere's clinical endocrinology and metabolism.

[25]  G. Williamson,et al.  Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[26]  H. Chen,et al.  Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells. , 1998, Biochemical pharmacology.

[27]  J. Phang,et al.  Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. , 1998, Cancer research.

[28]  Amy S. Lee,et al.  Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy. , 1998, Journal of the National Cancer Institute.

[29]  K. Setchell,et al.  Exposure of infants to phyto-oestrogens from soy-based infant formula , 1997, The Lancet.

[30]  J. Lakritz,et al.  Quantitative profiling of tissue- and gender-related expression of glutathione S-transferase isoenzymes in the mouse. , 1997, The Biochemical journal.

[31]  J. Magdalou,et al.  Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. , 1996, Toxicology.

[32]  P. Murphy,et al.  Bioavailability of soybean isoflavones depends upon gut microflora in women. , 1995, The Journal of nutrition.

[33]  B. Goldin,et al.  Soybean phytoestrogen intake and cancer risk. , 1995, The Journal of nutrition.

[34]  H. Adlercreutz,et al.  Plasma concentrations of phyto-oestrogens in Japanese men , 1993, The Lancet.

[35]  C. Green,et al.  Effects of soya bean flakes and liquorice root extract on enzyme induction and toxicity in B6C3F1 mice. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  S. Shukla,et al.  Involvement of tyrosine kinase and protein kinase C in platelet-activating-factor-induced c-fos gene expression in A-431 cells. , 1992, The Biochemical journal.

[37]  T. Yoshinari,et al.  Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. , 1988, Biochemical and biophysical research communications.

[38]  A. Santamaria,et al.  Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. , 1988, Analytical biochemistry.

[39]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[40]  P. Talalay,et al.  Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Mulder,et al.  A rapid NAD+-linked assay for microsomal uridine diphosphate glucuronyltransferase of rat liver and some observations on substrate specificity of the enzyme. , 1975, The Biochemical journal.

[42]  W B Jakoby,et al.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.

[43]  R. Michael McClain,et al.  Genetic toxicity studies with genistein. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[44]  M. Montano,et al.  Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage. , 2005, The Biochemical journal.

[45]  D. Lubahn,et al.  In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens. , 2004, Endocrinology.

[46]  L. Dragsted,et al.  Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[47]  A. Gescher,et al.  The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cells. , 1997, Xenobiotica; the fate of foreign compounds in biological systems.

[48]  S. Barnes,et al.  Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. , 1993, Nutrition and cancer.